La. Bland et al., POTENCY OF ENDOTOXIN FROM BICARBONATE DIALYSATE COMPARED WITH ENDOTOXINS FROM ESCHERICHIA-COLI AND SHIGELLA-FLEXNERI, Journal of the American Society of Nephrology, 5(8), 1995, pp. 1634-1637
Endotoxin is a potent activator of the complement system and other hos
t immunoregulators, including the cytokines, tumor necrosis factor alp
ha, interleukin-1 beta, and interleukin-6. In this study, the potency
of an endotoxin from bicarbonate dialysate was compared with endotoxin
s from two enteric microorganisms, Shigella flexneri and Escherichia c
oli. Endotoxin concentrations were standardized for the three endotoxi
ns by use of the limulus amebocyte lysate turbidimetric assay. Endotox
in potency was assessed by the comparative plasma concentrations of tu
mor necrosis factor alpha, interleukin-1 beta, and interleukin-6 after
an in vitro whole-blood challenge by each type of endotoxin. Blood co
llected from 10 hemodialysis patients was spiked with 0.1, 1, and 10 n
g/mL of E. coli and Shigella endotoxin and with 1 and 10 ng/mL of bica
rbonate dialysate endotoxin. After incubation, plasma was separated an
d frozen at -70 degrees C until assayed for cytokine concentrations. D
ialysate endotoxin was found to be 10 to 100 times less potent than E.
coli and Shigella endotoxins. It was concluded that there are signifi
cant differences in the potency of endotoxins from different strains o
f bacteria and that these differences should be noted when designing o
r evaluating studies on the clinical effects of endotoxins in hemodial
ysis settings.